Schizophrenia & Psychosis at 39th ECNP Congress

6 sessions on schizophrenia & psychosis · October 10–13, 2026, Munich, Germany. Compare schizophrenia & psychosis at other meetings →

Saturday, October 10

Lecture
E01 – Targeting the immune pathogenesis for the development of novel diagnostics and therapeutics of affective and non-affective psychosis
Paolo Enrico · Rachel Upthegrove
Educational update on immune-molecular patient stratification and multimodal inflammation measures in early psychosis.
Inflammation & Immunopsychiatry · Pharmacogenomics & Precision Psychiatry

Plenary
PL02 – ECNP Neuropsychopharmacology Award Lecture – How will we get novel medicines in psychiatry? Lessons from schizophrenia
Oliver Howes
Award lecture drawing lessons from schizophrenia drug development for the broader pipeline of novel psychiatric medicines.
Drug Pipeline & Clinical Trials
Symposium
S06 – Retinal imaging in mental disorders: a novel lens on central nervous system dysfunction
Steven Silverstein · Philipp Homan · Kathrin Nickel
Retinal neural and microvascular changes as accessible windows on CNS dysfunction in psychosis and autism.
Autism & Neurodevelopmental Disorders · Neuroscience & Mechanisms

Symposium
S15 – Novel Therapies Symposium – showcasing clinical trials on emerging compounds and new medical devices
Lone Baandrup · Viktoria Damgaard · Daniel Umbricht · Susan L. Rossell · Alexandra Philipsen · Mikołaj Matłoka
Trial results on emerging treatments including cannabidiol vs risperidone for cannabis-related psychosis (CANRISE), a novel oral NMDA antagonist, PDE10A inhibition in schizophrenia, and digital devices.
Cannabis & Cannabinoids · Drug Pipeline & Clinical Trials
Symposium
MS04 – EAN Mini Symposium – Rethinking the psychiatric approach in neurology conditions: in case of movement disorders
Anna Rita Bentivoglio · Jaime Kulisevsky
Joint neurology session on psychiatric management in Huntington's disease and Parkinson's disease psychosis.
Tardive Dyskinesia & Movement Disorders · Medical Comorbidity & C-L Psychiatry

Symposium
S22 – Excess mortality in people with mental health problems – influence of comorbidity
Elias Wagner · Ana Jiménez Peinado · Toby Pillinger · J. John Mann
Evidence on premature mortality in anxiety, bipolar disorder, and schizophrenia, and the role of physical comorbidity and inflammation.
Inflammation & Immunopsychiatry · Serious Mental Illness · Medical Comorbidity & C-L Psychiatry